Navigation Links
Chinese Distribution Contract Extended for an Additional 4 Years
Date:2/5/2010

FOUNTAIN HILLS, Ariz., Feb. 5 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ) announced today that they have extended the exclusive distribution agreement with Beijing Vision World Trading Co., Ltd. for an additional 4 years.

"I am very happy to sign this agreement," states G. Richard Smith, CEO of Sunridge International (www.sunridgeint.com). "We have worked closely with Beijing Vision World Trading Co., Ltd. (BV) over the last 3 1/2 years to complete the registration process for Pneumatic Trabeculoplasty, 'PNT' in China."

PNT is a two-minute, noninvasive, cost effective, alternative treatment for glaucoma and ocular hypertension, which was developed and patented by Ophthalmic International (www.oi-pnt.com), Sunridge Internationals wholly owned subsidiary.

"The registration process for a medical device and treatment is very strict in China.  It is a very long, expensive and tedious procedure," states Mr. Smith.  BV has worked tirelessly over the last 3 1/2 years at a tremendous financial cost to its company to compete this process.  They have performed several successful clinical trials at both private and state military hospitals as part of this effort.  With approval expected in the very near future, BV is now concentrating on its marketing efforts.  They have ordered and received delivery on 5 units with a substantial number of disposable rings, to be placed in 5 major hospitals in Beijing.  These hospitals will be used as models for the rest of the country.  They are currently negotiating with a number of companies to act as sub distributors to expand distribution throughout all of China.  They are attending different levels of Academy Conferences and Exhibitions as part of their "PNT" awareness program.  Doctors and distributor personal are being trained.  BV is doing everything possible to ensure the successful marketing of PNT in China.

Mr. Smith goes on to say, "that this is a significant event for OI.  China is a major market for us, with millions of Glaucoma patients.  The fact that a 'PNT' treatment lasts 3-4 months as a rule, with little or no side effects, makes it a very viable treatment for not only for the people of China, but for people everywhere.  We expect that this will prove to be a very profitable market for OI."

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

CONTACT:  Jeff Smith of Sunridge International, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International

RELATED LINKS
http://www.sunridgeint.com/
http://www.oi-pnt.com/

'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tainted Chinese Food Ingredients First Discovered in 2005
2. Chinese SFDA Grants Immtech Fast Track Status
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
5. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
6. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Reportlinker Adds Chinese Markets for Respiratory Drugs
9. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
10. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
11. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Germany Cataract Surgery Devices Market Outlook ... Cataract Surgery Devices Market Outlook to 2022", provides key ... The report provides value, in millions of US dollars, ... segements - Phacoemulsification Equipment and Ophthalmic Viscoelastic Devices (OVD). ... shares data for each of these market segements, and ...
(Date:1/19/2017)... Jan. 19, 2017 Report Details ... Which areas are going to grow at the fastest ... 2026, assessing data, trends, opportunities and prospects. Our ... the most lucrative areas in the industry and the ... forecasted sales across the all the major categories of ...
(Date:1/19/2017)... , Jan. 19, 2017 The U.S. Food ... of Chronic Idiopathic Constipation (CIC) in adult patients. ... chronic gastrointestinal disorders," said Julie Beitz , M.D., director ... Center for Drug Evaluation and Research. "With the availability of ... appropriate treatment for their condition." ...
Breaking Medicine Technology:
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The ... Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety ...
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a company ... January ECRM trade show to continue the marketing and distribution of its product, The ... for providing 400 percent better absorption than traditional vitamin C supplements. At the trade ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... ... Word: Chocolate Biscuit”: a biographical account following a man who went on to support his ... Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, his family ... age, he joined the Navy and got married right out of boot camp. , ...
Breaking Medicine News(10 mins):